Robert J Bitterman
CIK 1304395 · Chairman, Pres. & CEO · last filed 2026-02-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$440.2K
Companies
4
Total Filings
36
Lifetime Open-Market Net
$59.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PHIO | Chairman, Pres. & CEO | 411,421 | $1.07 | $440.2K | $53.5K | 24 | 2026-02-06 |
| Phio Pharmaceuticals Corp. (PHIOW) Delisted | Director | 15,826 | $0.02 | $367 | $0 | 3 | 2021-03-03 |
| Phio Pharmaceuticals Corp. (RXIIW) Delisted | Director | 10,440 | — | — | $0 | 2 | 2018-08-03 |
| Phio Pharmaceuticals Corp. (RXII) Delisted | Director | 44,000 | — | — | $6.0K | 4 | 2016-02-12 |
Recent Filings · Page 3 of 4
36 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-11-29 | PHIO | Buy (P) | +2,715 | $1.1K | EDGAR |
| 2022-11-16 | PHIO | Buy (P) | +1 | $1.8K | EDGAR |
| 2022-10-03 | PHIO | Grant (A) | +40,000 | $0 | EDGAR |
| 2022-02-16 | PHIO | Grant (A) | +10,000 | $0 | EDGAR |
| 2021-03-03 | Phio Pharmaceuticals Corp. (PHIOW) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2019-11-20 | Phio Pharmaceuticals Corp. (PHIOW) Delisted | Grant (A) | +300,000 | $30.0K | EDGAR |
| 2019-02-15 | Phio Pharmaceuticals Corp. (PHIOW) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2018-08-03 | Phio Pharmaceuticals Corp. (RXIIW) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2017-02-03 | Phio Pharmaceuticals Corp. (RXIIW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-02-12 | Phio Pharmaceuticals Corp. (RXII) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.